Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesWomens ImagingDBT shows advantages over mammography in TMIST Lead-in analysisDBT could improve screening performance over conventional mammography in age groups not eligible for the TMIST study.CTRadiomics adds value to CT-feature model for predicting pleural invasionPractice ManagementWhat is the impact of the 2026 Medicare Fee Schedule changes on radiology practices?UltrasoundBeyond commoditization: How ultrasound AI vendors can thriveMRIObesity's effect on brain health depends on where fat is stored
